Aerie Pharmaceuticals, Inc. AERI Balance Sheet

Aerie pharmaceuticals, inc. (AERI)

Balance Sheet / Yearly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Dec'12
Assets
Current assets
Cash and cash equivalents
134,179	143,940	248,702	109,363	148,868	202,818	234,954	270,648	249,501	197,569	194,078	242,650	139,534	197,945	211,938	58,519	74,266	91,060	106,946	100,916	113,450	85,586	148,884	27,876	35,843	69,649	4,619	2,925
Short-term investments
130,552	165,250	92,075	-	-	0	1,000	15,455	84,476	52,086	87,256	65,269	68,330	35,717	41,694	48,512	45,023	45,502	48,292	57,873	56,286	54,339	22,177	28,448	29,268	0	-	-
Accounts receivable, net
42,941	38,354	33,278	25,650	14,758	2,715	1,961	1,125	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Inventory
20,225	21,054	14,673	10,419	10,192	10,112	5,612	5,747	1,062	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses and other current assets
10,540	7,744	7,940	8,678	6,499	4,530	3,290	2,503	6,115	4,487	2,065	2,057	2,351	4,028	2,910	1,171	1,402	1,865	1,348	1,118	1,219	1,122	656	930	672	618	117	113
Deferred offering costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,330	-
Total current assets
338,437	376,342	396,668	154,110	180,317	220,175	246,817	295,478	341,154	254,142	283,399	309,976	210,215	237,690	256,542	108,202	120,691	138,427	156,586	159,907	170,955	141,047	171,717	57,254	65,783	70,267	7,066	3,038
Long-term investments
-	-	5,020	-	-	-	-	-	-	-	901	-	-	-	1,970	5,105	11,480	13,808	7,707	4,140	9,574	18,275	-	249	-	0	-	-
Property, plant and equipment, net
57,223	58,147	58,277	58,595	62,982	60,525	58,360	54,879	47,810	31,932	19,246	14,391	12,532	7,857	4,607	3,844	3,993	3,816	2,912	1,703	796	240	228	160	146	132	114	133
Operating lease right-of-use assets
15,465	16,523	17,216	17,882	16,394	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other assets
1,152	1,596	2,027	3,554	3,357	4,344	4,017	2,604	2,079	4,202	2,656	2,617	2,661	2,707	2,799	2,979	3,037	3,076	8,034	10,587	13,872	273	1,338	39	32	59	62	48
Total assets
412,277	452,608	479,208	234,141	263,050	285,044	309,194	352,961	391,043	290,276	306,202	326,984	225,408	248,254	265,918	120,130	139,201	159,127	175,239	176,337	195,197	159,835	173,283	57,702	65,961	70,458	7,242	3,219
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable
9,208	12,770	11,480	9,098	11,121	12,403	7,066	8,757	6,066	6,245	-	-	-	5,610	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued expenses and other current liabilities
64,323	65,376	55,728	46,523	35,810	38,381	27,948	20,016	19,070	18,939	18,045	13,265	13,023	13,761	13,547	13,598	15,501	16,565	17,961	17,710	21,852	8,336	6,999	4,846	3,690	3,482	3,175	1,437
Operating lease liabilities
5,614	5,502	5,802	5,494	5,032	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest payable
-	-	-	-	-	-	-	-	-	-	551	545	539	-	551	545	545	551	551	545	539	551	-	-	-	0	504	16
Notes payable, net of discount-related parties
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	14,433	2,331
Total current liabilities
79,145	83,648	73,010	61,115	51,963	50,784	35,014	28,773	25,136	25,184	18,596	13,810	13,562	19,371	14,098	14,143	16,046	17,116	18,512	18,255	22,391	8,887	6,999	4,846	3,690	3,482	18,112	3,784
Carrying value
193,833	188,651	183,553	-	-	0	0	123,999	123,922	123,845	123,769	123,692	123,615	123,539	123,463	123,387	123,310	123,236	124,250	124,218	124,187	122,906	124,125	-	-	0	-	-
Long-term operating lease liabilities
10,829	12,102	12,235	13,238	12,044	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other non-current liabilities
1,261	1,257	1,206	4,030	6,893	6,454	5,598	5,309	5,714	5,648	4,569	4,440	4,115	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warrants liability-related parties
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11,485	2,456
Total liabilities
285,068	285,658	270,004	78,383	70,900	57,238	40,612	158,081	154,772	154,677	146,934	141,942	141,292	142,910	137,561	137,530	139,356	140,352	142,762	142,473	146,578	131,793	131,124	4,846	3,690	3,482	29,597	6,240
Commitments and contingencies (Note 12)
-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Convertible preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	61,311	60,898
Stockholders’ equity
Preferred stock, $0.001 par value; 15,000,000 shares authorized as of March 31, 2020 and December 31, 2019; none issued and outstanding
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0
Common stock, $0.001 par value; 150,000,000 shares authorized as of March 31, 2020 and December 31, 2019; 46,476,185 and 46,464,669 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively
46	46	46	46	46	45	45	40	40	37	36	36	34	33	33	27	27	26	26	25	25	24	24	24	23	23	1	1
Additional paid-in capital
1,072,412	1,062,996	1,050,252	947,246	936,474	924,180	913,499	754,437	740,952	597,318	562,545	555,930	426,597	422,002	415,638	246,070	240,154	236,492	229,670	213,106	209,092	171,326	168,844	166,398	164,008	162,021	1,123	-
Accumulated other comprehensive loss
-120	-92	-158	-	-	0	-1	-9	-157	-28	-98	-81	-105	-68	-13	-10	-68	-179	-32	-41	-58	-107	-9	-13	-21	0	-	-
Accumulated deficit
-945,129	-896,000	-840,936	-791,534	-744,370	-696,419	-644,961	-559,588	-504,564	-461,728	-403,215	-370,843	-342,410	-316,623	-287,301	-263,487	-240,268	-217,564	-197,187	-179,226	-160,440	-143,201	-126,700	-113,553	-101,739	-95,068	-84,790	-63,920
Total stockholders’ equity
127,209	166,950	209,204	155,758	192,150	227,806	268,582	194,880	236,271	135,599	159,268	185,042	84,116	105,344	128,357	-17,400	-155	18,775	32,477	33,864	48,619	28,042	42,159	52,856	62,271	66,976	-83,666	-63,919
Total liabilities and stockholders’ equity
412,277	452,608	479,208	234,141	263,050	285,044	309,194	352,961	391,043	290,276	306,202	326,984	225,408	248,254	265,918	120,130	139,201	159,127	175,239	176,337	195,197	159,835	173,283	57,702	65,961	70,458	7,242	3,219